Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$175K Sell
33,879
-39,921
-54% -$250K ﹤0.01% 3904
2025
Q4
$539K Sell
73,800
-20,030
-21% -$194K ﹤0.01% 3595
2025
Q3
$935K Buy
93,830
+8,816
+10% +$97.6K ﹤0.01% 3396
2025
Q2
$769K Sell
85,014
-46,396
-35% -$303K ﹤0.01% 3373
2025
Q1
$844K Sell
131,410
-6,503
-5% -$57.9K ﹤0.01% 3272
2024
Q4
$1.31M Sell
137,913
-11,872
-8% -$104K ﹤0.01% 3118
2024
Q3
$1.22M Buy
149,785
+24,542
+20% +$255K ﹤0.01% 3130
2024
Q2
$1.69M Sell
125,243
-8,162
-6% -$68.3K ﹤0.01% 2936
2024
Q1
$935K Sell
133,405
-997,760
-88% -$8.66M ﹤0.01% 3189
2023
Q4
$12.4M Buy
1,131,165
+974,429
+622% +$9.57M ﹤0.01% 1611
2023
Q3
$1.72M Sell
156,736
-3,635
-2% -$52K ﹤0.01% 2888
2023
Q2
$2.5M Buy
160,371
+48,309
+43% +$562K ﹤0.01% 2768
2023
Q1
$1.44M Buy
112,062
+40,219
+56% +$330K ﹤0.01% 2995
2022
Q4
$782K Sell
71,843
-10,568
-13% -$130K ﹤0.01% 3235
2022
Q3
$1.32M Buy
+82,411
New +$1.22M ﹤0.01% 2979

Other funds holding ENVX

Ameriprise's ENVX Position: Q1 2026 in Review

Ameriprise reduced its Enovix (ENVX) stake by 54% in Q1 2026, selling an estimated $250K and leaving 33,879 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #3904.

Ameriprise first reported a position in ENVX in Q3 2022 and has held it in 15 quarters since. The position peaked at $12.4M in Q4 2023. 306 funds tracked by Wall St. Rank hold ENVX as of Q1 2026.

  • Ameriprise held 33,879 shares of Enovix worth $175K as of Q1 2026.
  • Ameriprise sold 39,921 Enovix shares in Q1 2026, an estimated $250K.
  • Enovix made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3904 holding.
  • Ameriprise first reported a position in Enovix in Q3 2022 and has held it in 15 quarters since.
  • Ameriprise's Enovix position peaked at $12.4M in Q4 2023.
  • 306 funds tracked by Wall St. Rank held Enovix as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.